Merger of CyBio AG into Analytik Jena AG Completed
"With the successful merger we have finally completed the multi-year integration process of CyBio AG into the Analytik Jena Group. As a result, we are combining the technological expertise and employee resources of both companies and are also in a position to configure our internal organizational structures much more effectively," said Klaus Berka, Chief Executive Officer of Analytik Jena AG.
Analytik Jena AG acquired all still outstanding shares of CyBio AG in connection with the merger. The overwhelming majority of shareholders of CyBio AG drafted a corresponding resolution to transfer the shares of the minority shareholders to Analytik Jena AG as the majority shareholder in return for payment of compensation in cash at the company's General Meeting on May 22, 2014.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.